Solid gastric emptying mediated by the serotonin (5-HT)3 receptor in mice is a simple marker to predict emesis

Journal of Toxicological Sciences

Volumn 36, Issue 1, 2011, Pages 23-29

  Ando, Kentaro ^a   Takagi, Kan ^b  

^a UNIVERSITY OF TOKYO   (Japan)

^b MITSUBISHI TANABE PHARMA CORPORATION   (Japan)

Author keywords

Chemotherapeutics; Emesis; Gastric emptying; Mice; Nausea

Indexed keywords

APOMORPHINE; ATROPINE; BIOLOGICAL MARKER; CISPLATIN; COPPER SULFATE; DOXORUBICIN; ONDANSETRON; PHENOLSULFONPHTHALEIN; RESIN; SALCATONIN; SEROTONIN 3 RECEPTOR;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; DOSE RESPONSE; DRUG ANTAGONISM; DRUG EFFECT; GASTROINTESTINAL TRANSIT; LIQUID; MALE; MOUSE; NAUSEA; NONHUMAN; PREDICTION; SOLID; SOLID STOMACH EMPTYING; STOMACH EMPTYING; VOMITING;

MUS;

EID: 79551610282     PISSN: 03881350     EISSN: 18803989     Source Type: Journal    
DOI: 10.2131/jts.36.23     Document Type: Article

References (21)

1. Andrews, P.L.R., Kovacs, M. and Watson, J.W. (2001): The antiemetic action of the neurokinin1 receptor antagonist CP-99,994 does not require the presence of the area postrema in the dog. Neurosci. Lett., 314, 102-104.
2. Andrews, P.L.R., Rapeport, W.G. and Sanger, G.J. (1988): Neuropharmacology of emesis induced by anti-cancer therapy. Trends. Pharmacol. Sci., 9, 334-341.
3. Bhandari, P. and Andrews, P.L.R. (1991): Preliminary evidence for the involvement of the putative 5-HT4 receptor in zacopride- and copper sulphate-induced vomiting in the ferret. Eur. J. Pharmacol., 204, 273-280.
4. Costall, B., Domeney, A.M., Naylor, R.J., Owera-Atepo, J.B., Rudd, J.A. and Tattersall, F.D. (1990): Fluphenazine, ICS 205-930 and dl-fenfluramine differentially antagonise drug-induced emesis in the ferret. Neuropharmacology, 29, 453-462.
5. Green, T. and Dockray, GJ. (1988): Characterization of the peptidergic afferent innervation of the stomach in the rat, mouse and guinea-pig. Neuroscience, 25, 181-193.
6. Hinder, R.A. and Kelly, K.A. (1977): Canine gastric emptying of solids and liquids. Am. J. Physiol., 233, E335-340.
7. King, G.L. (1990): Animal models in the study of vomiting. Can. J. Physiol. Pharmacol., 68, 260-268.
8. Lau, A.H., Kan, K.K., Lai, H.W., Ngan, M.P., Rudd, J.A., Wai, M.K. and Yew, D.T. (2005): Action of ondansetron and CP-99,994 to modify behavior and antagonize cisplatin-induced emesis in the ferret. Eur. J. Pharmacol., 506, 241-247.
9. Malik, N.M., Liu, Y.L., Cole, N., Sanger, G.J. and Andrews, P.L.R. (2007): Differential effects of dexamethasone, ondansetron and a tachykinin NK1 receptor antagonist (GR205171) on cisplatin-induced changes in behaviour, food intake, pica and gastric function in rats. Eur. J. Pharmacol., 555, 164-173.
10. Mitchell, D., Wells, C., Hoch, N., Lind, K., Woods, S.C. and Mitchell, L.K. (1976): Poison induced pica in rats. Physiol. Behav., 17, 691-697.
11. Nakamura, H., Asano, T., Haruta, K. and Takeda, K. (1995): Gastrointestinal motor inhibition by exogenous human, salmon, and eel calcitonin in conscious dogs. Can. J. Physiol. Pharmacol., 73, 43-49.
12. Nakayama, H., Yamakuni, H., Higaki, M., Ishikawa, H., Imaizumi, K., Matsuo, M. and Mutoh, S. (2005): Antiemetic activity of FK1052, a 5-HT3- and 5-HT4-receptor antagonist, in Suncus murinus and ferrets. J. Pharmacol. Sci., 98, 396-403.
13. Takeda, N., Hasegawa, S., Morita, M., Horii, A. Uno, A., Yamatodani, A. and Matsunaga, T. (1995a): Neuropharmacological mechanisms of emesis. I. Effects of antiemetic drugs on motion- and apomorphine-induced pica in rats. Methods Find. Exp. Clin. Pharmacol., 17, 589-590.
14. Takeda, N., Hasegawa, S., Morita, M., Horii, A., Uno, A., Yamatodani, A. and Matsunaga, T. (1995b): Neuropharmacological mechanisms of emesis. II. Effects of antiemetic drugs on cisplatin-induced pica in rats. Methods Find. Exp. Clin. Pharmacol., 17, 647-652.
15. Takeda, N., Hasegawa, S., Morita, M. and Matsunaga, T. (1993): Pica in rats is analogous to emesis: An animal model in emesis research. Pharmacol. Biochem. Behav., 45, 817-821.
16. Tanihata, S., Oda, S., Nakai, S. and Uchiyama, T. (2004): Antiemetic effect of dexamethasone on cisplatin-induced early and delayed emesis in the pigeon. Eur. J. Pharmacol., 484, 311-321.
17. Wüster, C., Schurr, W., Scharla, S., Raue, F., Minne, H.W. and Ziegler, R. (1991): Superior local tolerability of human versus salmon calcitonin preparations in young healthy volunteers. Eur. J. Clin. Pharmacol., 41, 211-215.
18. Yamamoto, K., Nakai, M., Nohara, K. and Yamatodani, A. (2007): The anti-cancer drug-induced pica in rats is related to their clinical emetogenic potential. Eur. J. Pharmacol., 554, 34-39.
19. Yamamoto, K., Ngan, M.P., Takeda, N., Yamatodani, A. and Rudd, J.A. (2004): Differential activity of drugs to induce emesis and pica behavior in Suncus murinus (house musk shrew) and rats. Physiol. Behav., 83, 151-156.
20. Yamamoto, K., Nohara, K., Furuta, T. and Yamatodani, A. (2005): Ondansetron, dexamethasone and an NK1 antagonist block radiation sickness in mice. Pharmacol. Biochem. Behav., 82, 24-29.
21. Yoshikawa, T., Yoshida, N. and Oka, M. (2001): The broad-spectrum anti-emetic activity of AS-8112, a novel dopamine D2, D3 and 5-HT3 receptors antagonist. Br. J. Pharmacol., 133, 253-260.